Insights

Strong Market Presence Mayne Pharma’s established presence in the global pharmaceutical market with over 90 marketed products and a market capitalization exceeding A$500 million presents a solid foundation for expanding sales channels and forming strategic partnerships to drive growth.

Innovation Focus With a 40-year track record in developing oral drug delivery systems and a focus on novel and generic pharmaceuticals, Mayne Pharma offers opportunities to collaborate on innovative formulations and specialized drug development projects.

Contract Manufacturing Capabilities Operating a full-service CDMO (Mayne Contract Services) in Australia, the company is receptive to partnership opportunities for manufacturing, licensing, and distributing new or existing pharmaceutical products globally, opening avenues for supply chain expansion.

Regulatory and Ethical Leadership Mayne Pharma’s commitment to high standards in corporate governance and ethical conduct indicates a reliable partner for compliant and transparent collaborations across various markets, enhancing trustworthiness for joint ventures.

Legal and Patent Focus Recent patent infringement disputes signal an active focus on intellectual property rights, making the company a strategic partner for companies interested in patent licensing, rights enforcement, and protecting innovative formulations in competitive markets.

Mayne Pharma Tech Stack

Mayne Pharma uses 8 technology products and services including PostgreSQL, Google Cloud, Modernizr, and more. Explore Mayne Pharma's tech stack below.

  • PostgreSQL
    Database
  • Google Cloud
    Infrastructure As A Service
  • Modernizr
    Javascript Libraries
  • Google Chat
    Live Chat
  • Office 365
    Office Suites
  • Priority Hints
    Performance
  • X-Content-Type-Options
    Web & Portal Technology
  • Zoom
    Web Conferencing

Media & News

Mayne Pharma's Email Address Formats

Mayne Pharma uses at least 1 format(s):
Mayne Pharma Email FormatsExamplePercentage
First.Last@maynepharma.comJohn.Doe@maynepharma.com
96%
Last.First@maynepharma.comDoe.John@maynepharma.com
3%
First.Middle@maynepharma.comJohn.Michael@maynepharma.com
1%

Frequently Asked Questions

What is Mayne Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Mayne Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Mayne Pharma's official website and social media links?

Minus sign iconPlus sign icon
Mayne Pharma's official website is maynepharma.com and has social profiles on LinkedIn.

How much revenue does Mayne Pharma generate?

Minus sign iconPlus sign icon
As of December 2025, Mayne Pharma's annual revenue is estimated to be $3.9B.

What is Mayne Pharma's NAICS code?

Minus sign iconPlus sign icon
Mayne Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Mayne Pharma have currently?

Minus sign iconPlus sign icon
As of December 2025, Mayne Pharma has approximately 572 employees across 5 continents, including North AmericaOceaniaEurope. Key team members include Chief Executive Officer And Managing Director: S. P. O.Chief Executive Officer: M. T.Ceo: S. R.. Explore Mayne Pharma's employee directory with LeadIQ.

What industry does Mayne Pharma belong to?

Minus sign iconPlus sign icon
Mayne Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Mayne Pharma use?

Minus sign iconPlus sign icon
Mayne Pharma's tech stack includes PostgreSQLGoogle CloudModernizrGoogle ChatOffice 365Priority HintsX-Content-Type-OptionsZoom.

What is Mayne Pharma's email format?

Minus sign iconPlus sign icon
Mayne Pharma's email format typically follows the pattern of First.Last@maynepharma.com. Find more Mayne Pharma email formats with LeadIQ.

Mayne Pharma

Pharmaceutical ManufacturingSouth Australia, Australia501-1000 Employees

Mayne Pharma is an ASX-listed specialty pharmaceutical Company (ASX: MYX) focused on commercializing novel and generic pharmaceuticals. We offer patients better, safe and more accessible medicines. 

Mayne Pharma has a 40-year track record of innovation and success in developing oral drug delivery systems. These technologies have been successfully commercialized in numerous products that continue to be marketed around the world.  

Mayne Pharma also has a full service contract development and manufacturing organizations (CDMO) servicing clients worldwide:  Mayne Contract Services is based in Salisbury, SA, Australia

Here are some key facts about our company: 
•	400+ staff
•	A$500m+ market cap 
•	A$400m+ in revenue (FY22) 
•	A product portfolio of 90+ marketed products globally
 
The Company's corporate values are: 
 
•	Empowerment – encouraging everyone to take initiative, enabling growth and achievement. 
•	Passion – showing pride, enthusiasm and dedication in everything we do.
•	Creativity – delivering value and striving to connect new ideas with business realities.
•	Agility – operating with timeliness as well as mental, emotional and physical flexibility.   
•	Integrity – maintaining high ethical standards, demonstrating honesty, and respecting fairness by doing the right thing, even when no one is looking.
•	Accountability – accepting our individual and team responsibilities, meeting our commitments, and acknowledging and learning from mistakes.

To learn more, visit us at www.maynepharma.com. Our social media policy: https://bit.ly/3py3L1e

Any communication you receive from Mayne Pharma will never come from a personal email domain or chat service such as "gmail" or "Google Chat".  All official communication from Mayne Pharma will be received from our company email domain - @maynepharma.com.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $250M$500M

    Mayne Pharma's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Mayne Pharma's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.